Austedo
Total Payments
$1.2M
Transactions
1,383
Doctors
13
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $398,535 | 895 | 12 |
| 2018 | $753,938 | 488 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.2M | 1,382 | 100.0% |
| Education | $57.50 | 1 | 0.0% |
Payments by Type
Research
$1.2M
1,382 transactions
General
$57.50
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| An Open-Label, Long-Term Safety Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia | Teva Pharmaceuticals USA, Inc. | $855,323 | 0 |
| An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease | Teva Pharmaceuticals USA, Inc. | $215,581 | 0 |
| A Randomized, Double-Blind, Placebo-Controlled Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents | Teva Pharmaceuticals USA, Inc. | $81,512 | 12 |
Top Doctors Receiving Payments for Austedo
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Miami, FL | $1.1M | 1,308 |
| , MD | Specialist | Tampa, FL | $3,090 | 6 |
| , D.O | Neurology with Special Qualifications in Child Neurology | Birmingham, AL | $2,480 | 6 |
| , M.D | Neurodevelopmental Disabilities | Birmingham, AL | $2,286 | 8 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Miami, FL | $2,122 | 6 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Rochester, NY | $2,102 | 6 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Phoenix, AZ | $1,953 | 6 |
| , M.D | Neurodevelopmental Disabilities | Nashville, TN | $1,808 | 6 |
| , M.D | Pediatrics | Houston, TX | $1,800 | 2 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Houston, TX | $1,782 | 7 |
| , MD | Neurology with Special Qualifications in Child Neurology | Voorhees, NJ | $1,766 | 6 |
| , M.D | Neurology | Nashville, TN | $1,560 | 8 |
| , MD | Neurology with Special Qualifications in Child Neurology | Atlanta, GA | $680.85 | 7 |
| , M.D | Addiction Psychiatry | Myrtle Beach, SC | $57.50 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $1.2M
- Total Doctors 13
- Transactions 1,383
About Austedo
Austedo is a drug associated with $1.2M in payments to 13 healthcare providers, recorded across 1,383 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2018 to 2019. In 2019, $398,535 was paid across 895 transactions to 12 doctors.
The most common payment nature for Austedo is "Unspecified" ($1.2M, 100.0% of total).
Austedo is associated with 3 research studies, including "An Open-Label, Long-Term Safety Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia" ($855,323).